Home
About
Sonnet Overview
Sonnet Management Team
Sonnet CEO Corner
Technology
Overview
Platform
Publications
Pipeline
Overview
SON-1010
SON-1210
SON-080
Clinical Trials
Partnering
News & Media
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Stock Data
SEC Filings
Governance
Contact
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “
PURR
”
Full Press Release Here
Governance Documents
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Governance Documents
Governance
Governance Documents
Code of Ethics and Conduct
Download
Code of Ethics and Conduct
Audit and Risk Committee Charter
Download
Audit and Risk Committee Charter
Compensation Committee Charter
Download
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Download
Nominating and Corporate Governance Committee Charter
Email Alerts
Tear Sheet
Contacts
RSS News Feed